Viveon Health Acquisition Corp. (VHAQ)
USD 10.0
(0.0%)
USD 10.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 545 Thousand | 1.55 Billion | 446 Million |
| Cost of Revenue | 756.38 Thousand | 1.05 Million | - | 3.56 Million | 2.24 Billion | 3.07 Billion |
| Gross Profit | -756.38 Thousand | -1.05 Million | - | -3.01 Million | -689 Million | -2.62 Billion |
| Operating Expenses | 2.37 Million | 4.1 Million | 450.47 Thousand | 6.27 Million | 7.53 Billion | 7.03 Billion |
| Selling, General and Administrative Expenses | 2.24 Million | 2.85 Million | 450.47 Thousand | - | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 1.24 Million | -26.03 Thousand | 303 Million | 1.21 Billion | 331 Million |
| Cost and Expenses | 2.37 Million | 4.1 Million | 450.47 Thousand | 9.83 Million | 9.77 Billion | 10.1 Billion |
| Operating Income | -2.37 Million | -4.1 Million | -450.47 Thousand | -9.28 Million | -8.22 Billion | -9.66 Billion |
| Interest Expense | 3.64 Million | - | - | - | - | - |
| Income Tax Expense | 61.31 Thousand | -20.47 Thousand | -1081.13 | 693.14 Thousand | -161.14 Thousand | -1.92 Million |
| Earnings before Tax | -425.47 Thousand | 2.48 Million | -2.23 Million | -9.22 Million | -8.13 Billion | -9.52 Billion |
| Net Income | -486.78 Thousand | 2.48 Million | -2.23 Million | -9.22 Million | -8.13 Billion | -9.52 Billion |
| Earnings Per Share Basic | -0.04 | 0.12 | -0.09 | - | - | - |
| Earnings Per Share Diluted | -0.04 | 0.12 | -0.09 | - | - | - |
| Weighted Average Shares Outstanding | 12.22 Million | 20.12 Million | 25.15 Million | 3.66 Million | 987.36 Thousand | 514.59 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 12.22 Million | 20.12 Million | 25.15 Million | 3.66 Million | 987.36 Thousand | 514.59 Thousand |
| Gross Margin | - | - | - | -5.54 | -0.44 | -5.89 |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | -16.93 | -5.23 | -21.36 |
| EBITDA | 1.94 Million | -4.08 Million | -450.47 Thousand | - | - | - |
| Earnings Before Tax Margin | - | - | - | -17.04 | -5.28 | -21.67 |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 12.48 Million | - |
| Cost of Revenue | - | - | 268.67 Thousand | 98.89 Thousand | 19.33 Million | 203.07 Thousand |
| Gross Profit | - | - | -268.67 Thousand | -98.89 Thousand | -6.84 Million | -203.07 Thousand |
| Operating Expenses | - | - | 53.74 Thousand | -281.52 Thousand | 24.34 Million | 939.76 Thousand |
| Selling, General and Administrative Expenses | - | - | 570.06 Thousand | -513.27 Thousand | - | 703.82 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | -132.86 Thousand | 1.97 Million | 235.94 Thousand |
| Cost and Expenses | - | - | 53.74 Thousand | -281.52 Thousand | 24.34 Million | 939.76 Thousand |
| Operating Income | - | - | -595.81 Thousand | 281.52 Thousand | -11.85 Million | -939.76 Thousand |
| Interest Expense | - | - | - | 2.54 Million | 3.72 Million | 737.93 Thousand |
| Income Tax Expense | - | - | 99.5 Thousand | 2.21 Million | 8.15 Million | 1.44 Million |
| Earnings before Tax | - | - | 163.43 Thousand | 3 Million | -14.46 Million | -2.38 Million |
| Net Income | - | - | 262.93 Thousand | 2.94 Million | -22.62 Million | -3.83 Million |
| Earnings Per Share Basic | - | - | 0.04 | 0.43 | - | -0.42 |
| Earnings Per Share Diluted | - | - | 0.04 | 0.43 | - | -0.42 |
| Weighted Average Shares Outstanding | - | - | 5.86 Million | 6.87 Million | 18.6 Million | 9.05 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | 5.86 Million | 6.87 Million | 18.6 Million | 9.05 Million |
| Gross Margin | - | - | - | - | -0.55 | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | -1.81 | - |
| EBITDA | - | - | 958.24 Thousand | 678.75 Thousand | - | -709.14 Thousand |
| Earnings Before Tax Margin | - | - | - | - | -0.95 | - |
9928
PTG
ADMQ
KOZAL
SIPTL
2805